What is the latest GLENMARK stock price?
The latest stored price for GLENMARK is Rs 2,632.90 as of 2026-11-16.
GLENMARK PHARMACEUTICALS is a mid-cap stock in Healthcare. This Gimli page shows the latest available GLENMARK price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for GLENMARK is Rs 2,632.90 as of 2026-11-16.
GLENMARK is above 50DMA, above 200DMA. The latest 50DMA is 2,386.35 and the latest 200DMA is 2,251.79.
GLENMARK has PE 51.20, ROE +14.99%, and ROCE +18.77% in Gimli's latest available snapshot.
GLENMARK has returned +18.24% over 1 month, +13.57% over 3 months, and +38.90% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 4,157.09 cr | 582.47 cr | 263.78 cr | 9.35 |
| 2026-06-30 | 3,931.73 cr | 870.56 cr | 482.92 cr | 17.11 |
| 2026-03-31 | 3,760.28 cr | 578.28 cr | 301.41 cr | 10.68 |
| 2025-12-31 | 3,888.00 cr | 729.88 cr | 403.21 cr | 14.29 |
| 2025-09-30 | 6,003.79 cr | 1,175.06 cr | 610.35 cr | 21.63 |
| 2025-06-30 | 3,059.33 cr | 283.73 cr | 46.87 cr | 1.66 |
| 2025-03-31 | 3,220.13 cr | 199.89 cr | 4.65 cr | 0.16 |
| 2024-12-31 | 3,301.90 cr | 631.36 cr | 347.96 cr | 12.33 |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 16,711.40 cr | 2,766.95 cr | 1,361.85 cr | 48.26 |
| 2025-03-31 | 13,145.84 cr | 2,092.28 cr | 1,047.10 cr | 37.11 |
| 2024-03-31 | 11,635.46 cr | 1,183.27 cr | -1,501.67 cr | -53.22 |
| 2023-03-31 | 11,431.94 cr | 1,200.15 cr | 297.25 cr | 10.53 |
| 2022-03-31 | 8,756.21 cr | 2,226.06 cr | 1,997.79 cr | nan |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 19,907.88 cr | 1,174.71 cr | 593.53 cr | 10,511.79 cr |
| 2025-03-31 | 16,049.55 cr | 1,675.71 cr | 2,472.67 cr | 8,849.07 cr |
| 2024-03-31 | 14,358.62 cr | 1,658.27 cr | 1,230.93 cr | 7,847.55 cr |
| 2023-03-31 | 19,371.68 cr | 1,159.20 cr | 4,607.88 cr | 9,839.26 cr |
| 2022-03-31 | 17,083.29 cr | 1,410.53 cr | 3,962.02 cr | 9,438.12 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 3,445.03 cr | 2,087.32 cr | n/a |
| 2025-03-31 | -827.60 cr | -1,578.32 cr | n/a |
| 2024-03-31 | -265.44 cr | -1,163.82 cr | n/a |
| 2023-03-31 | 625.39 cr | 17.63 cr | n/a |
| 2022-03-31 | 1,108.65 cr | 318.54 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +46.65% | +21.51% | +17.64% | +15.61% | +14.17% | +0.00% |
| 2026-06-30 | +46.65% | +20.89% | +18.60% | +16.76% | +13.81% | +0.00% |
| 2026-03-31 | +46.65% | +20.34% | +19.29% | +16.80% | +13.68% | +0.00% |
| 2025-12-31 | +46.65% | +19.20% | +20.09% | +17.86% | +14.02% | +0.00% |
| 2025-09-30 | +46.65% | +20.73% | +18.61% | +16.31% | +13.97% | +0.00% |
| 2025-06-30 | +46.65% | +20.62% | +17.64% | +15.55% | +15.06% | +0.00% |
| 2025-03-31 | +46.65% | +23.16% | +14.60% | +12.86% | +15.56% | +0.00% |
| 2024-12-31 | +46.65% | +23.51% | +13.85% | +12.12% | +15.96% | +0.00% |
| 2024-09-30 | +46.65% | +23.05% | +13.21% | +11.41% | +17.06% | +0.00% |
| 2024-06-30 | +46.65% | +20.98% | +13.92% | +10.92% | +18.41% | +0.00% |
| 2024-03-31 | +46.64% | +21.38% | +13.36% | +10.55% | +18.58% | +0.00% |
| 2023-12-31 | +46.65% | +23.71% | +10.92% | +8.59% | +18.69% | +0.00% |
| 2023-09-30 | +46.65% | +24.80% | +10.32% | +7.30% | +18.20% | +0.00% |
| 2023-06-30 | +46.65% | +25.52% | +9.11% | +5.36% | +18.68% | +0.00% |
| 2023-03-31 | +46.65% | +22.46% | +10.41% | +5.43% | +20.45% | +0.00% |
| 2022-12-31 | +46.65% | +23.20% | +10.69% | +5.64% | +19.43% | +0.00% |
| 2022-09-30 | +46.65% | +23.14% | +10.91% | +6.26% | +19.27% | +0.00% |
| 2022-06-30 | +46.65% | +0.00% | +34.73% | n/a | n/a | +0.00% |
| 2022-03-31 | +46.65% | +0.00% | +35.08% | n/a | n/a | +0.00% |
| 2021-12-31 | +46.65% | +0.00% | +35.04% | n/a | n/a | n/a |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
Data snapshot: 2026-11-16. Not investment advice.